Shanghai Amplicon-Gene Bioscience Co., Ltd. Wins '2026 Forbes China Industry Development Innovation Brand' AwardArticle content Shanghai, China–(Newsfile Corp. – July 30, 2026) – On March 18, 2026, Frost & Sullivan and Forbes China Group jointly hosted the 2026 FORBES CHINA PIONEER INNOVATORS IN INDUSTRY DEVELOPMENT SELECTION GALA BANQUET at the Bulgari Hotel in Shanghai. The awards, co-initiated by Forbes China Group and Frost & Sullivan, feature one main category-the “2026 Forbes China Industry Development Pioneer Innovators”-and three sub-categories: “2026 Forbes China Industry Development Leading Enterprises,” “2026 Forbes China Industry Development Innovative Brands,” and “2026 Forbes China Industry Development Emerging Analysts.” Amplicon-Gene has won the “2026 Forbes China Industry Development Innovation Brand” award, a recognition of its standing and comprehensive strength in the field of induced pluripotent stem cell (iPSC) technology innovation. AI Validation Platform and Digital Twin Cells: Pioneering a “Data-Algorithm-Experiment” Positive Feedback LoopAmplicon-Gene has built a four-tier, interconnected AI validation platform that integrates “Data – Algorithm – Virtual – Physical” into a complete drug discovery closed loop. The company is committed to becoming a core provider of China’s iPSC industrial infrastructure and to securing a dominant position in the future global iPSC industry landscape.